How will you celebrate your 89th Birthday? Rotarian-For-Life Jerry Kanter of the Kinston Evening Rotary Club decided he will swim 89 laps. Jerry will do his birthday swim at his favorite pool at the Woodmen Community Center in Kinston, NC. Those who know Jerry, know his passion for swimming. He has competed in every North […]read more
The CART Fund is pleased to announce follow-on funding for the research project begun by Ben Bahr, Ph.D. with a 2014 CART Grant.read more
The CART Fund is pleased to announce that Thomas J. Anastasio, Ph.D., University of Illinois, has been selected to receive a 2016 Alzheimer’s research grant in the amount of $50,000. The grant will be awarded on May 3, 2016 at the annual meeting of The CART Fund in Columbia, SC.
Research Project: Computational identification of possible combinations of existing drugs that reduce inflammation in AD with minimal side effects
Chronic inflammation is as destructive for the brain as it is for the rest of the body, and all neurodegenerative diseases, including Alzheimer Disease (AD), have a prominent inflammatory component. Many researchers now believe that inflammation is one of the main causes of nerve cell loss in AD. The cells that produce inflammation in the brain are called microglia. Like other immune-system cells, the behavior of microglia is extremely complex.read more
The CART Fund is pleased to announce that Gabriela Chiosis, Ph.D., Memorial Sloan Kettering Cancer Center, has been selected to receive a 2016 Alzheimer’s research grant in the amount of $50,000. The grant will be awarded on May 3, 2016 at the annual meeting of The CART Fund in Columbia, SC.
Research Project: A chemoproteomics approach to identify molecular changes in Alzheimer’s disease for therapy and diagnostic development
Current Alzheimer’s disease (AD) treatments only suppress symptoms as the disease continues to progress. For treatments that slow or reverse the disease, we must identify the proteins associated with AD progression before the neurons die. Attempts so far have been hindered by a lack of access to patient neurons in amounts sufficient for analyses and of sensitive techniques that inquire into biochemical changes that occur in neurons during disease initiation.read more